VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome
Clinical trial NCT01130246 · TERMINATED
Trial details
- NCT number
- NCT01130246
- Sponsor
- Anthera Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2012-03-01
- Enrollment
- 5189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.